Results 81 to 90 of about 17,300 (202)

ANALISIS EFEKTIVITAS BISOPROLOL TUNGGAL DENGAN KOMBINASI BISOPROLOL DAN AMLODIPIN PADA PASIEN PENYAKIT JANTUNG KORONER RAWAT INAP DI RUMAH SAKIT “X” [PDF]

open access: yes
Latar Belakang: Penyakit jantung koroner (PJK) adalah suatu keadaan dimana diakibatkan oleh penyempitan dan penyumbatan pembuluh darah yang mengalirkan darah ke otot jantung, sehingga jantung mengalami kekurangan darah dan tidak mendapatkan oksigen
Idelia, Lidwina Carissa Gladys
core  

Bisoprolol Therapy and The Risk of Erectile Dysfunction in Stable Coronary Artery Disease Patients

open access: yes, 2017
Background :Bisoprolol is an anti angina and ischemic therapy in patient with stable coronary artery disease (CAD). Moreover it can decrease mortality and rehospitalization rate up to 34 % and 28 %.
Hariawan, Hariadi   +2 more
core   +1 more source

KAJIAN INTERAKSI BISOPROLOL PADA PASIEN RAWAT INAP DI RUMAH SAKIT ISLAM SULTAN AGUNG SEMARANG PERIODE 2018 [PDF]

open access: yes, 2020
Bisoprolol digunakan dalam pengobatan pasien dengan penyakit gagal jantung, arteri koroner (CAD),hipertensi dan angina pectoris dalam kombinasi dengan obat lain.
Hasani Furdiyanti, Nova   +2 more
core  

Oral Bisoprolol Improves Surgical Field in Fess [PDF]

open access: yes, 2015
BACKGROUND: The success of functional endoscopic sinus surgery (FESS) depends on visual clarity of the surgical field, through the endoscope. The objective of this double-blind, randomized, controlled study was to determine if a pre-operative dose of ...
Jeyakkumar, R
core  

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To compare efficacy of carvedilol and bisoprolol in patients with chronic heart failure (CHF) and diabetes mellitus (DM) type 2 after myocardial infarction (MI).Material and methods.
M. E. Statsenko   +4 more
doaj   +1 more source

Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease

open access: yesТерапевтический архив, 2004
Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients ...
Т A Fedorova   +4 more
doaj  

Bisoprolol effectiveness in arterial hypertension and coronary heart disease [PDF]

open access: yes, 1970
The authors review the current evidence on the effectiveness of a highly selective b-adrenoblocker bisoprolol in the treatment of arterial hypertension and/or coronary heart disease.
O. D. Ostroumova   +2 more
core  

VISIBLE SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF BISOPROLOL FROM ITS BULK AND TABLET FORMULATION [PDF]

open access: yes, 2013
The proposed method is new, simple, sensitive, reproducible, economical, accurate and precise and can be successfully applied in estimation of bisoprolol. This method can find applications in clinical studies and therapeutic drug monitoring.
B. SHINDE, DATTATRYA   +3 more
core   +1 more source

Effects of β1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease

open access: yesТерапевтический архив, 2009
Aim. To study effects of a cardioselective beta-adrenoblocker bisoprolol on vascular wall endothelium and external respiration function in stable angina of effort combined with chronic obstructive pulmonary disease (COPD).
N Yu Grigor'eva   +11 more
doaj  

NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH BISOPROLOL AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE

open access: yesFolia Medica Indonesiana, 2017
Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP
Reine Risa Risthanti   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy